LT2958903T - Vortioksetino gamybos būdas - Google Patents

Vortioksetino gamybos būdas

Info

Publication number
LT2958903T
LT2958903T LTEP14705524.8T LT14705524T LT2958903T LT 2958903 T LT2958903 T LT 2958903T LT 14705524 T LT14705524 T LT 14705524T LT 2958903 T LT2958903 T LT 2958903T
Authority
LT
Lithuania
Prior art keywords
vortioxetine
manufacturing process
manufacturing
vortioxetine manufacturing
Prior art date
Application number
LTEP14705524.8T
Other languages
English (en)
Lithuanian (lt)
Inventor
Thomas Ruhland
Kim Lasse Christensen
Original Assignee
H. Lundbeck A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by H. Lundbeck A/S filed Critical H. Lundbeck A/S
Publication of LT2958903T publication Critical patent/LT2958903T/lt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/02Iron compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
LTEP14705524.8T 2013-02-22 2014-02-20 Vortioksetino gamybos būdas LT2958903T (lt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361767883P 2013-02-22 2013-02-22
DKPA201300104 2013-02-22
PCT/EP2014/053313 WO2014128207A1 (en) 2013-02-22 2014-02-20 Vortioxetine manufacturing process

Publications (1)

Publication Number Publication Date
LT2958903T true LT2958903T (lt) 2017-08-25

Family

ID=59215387

Family Applications (1)

Application Number Title Priority Date Filing Date
LTEP14705524.8T LT2958903T (lt) 2013-02-22 2014-02-20 Vortioksetino gamybos būdas

Country Status (37)

Country Link
US (1) US9353073B2 (enExample)
EP (1) EP2958903B1 (enExample)
JP (1) JP6464098B2 (enExample)
KR (1) KR102230628B1 (enExample)
CN (1) CN104995181B (enExample)
AP (1) AP2015008640A0 (enExample)
AU (1) AU2014220735B2 (enExample)
BR (1) BR112015019268B1 (enExample)
CA (1) CA2901821A1 (enExample)
CL (1) CL2015002309A1 (enExample)
CR (1) CR20150423A (enExample)
CY (1) CY1118883T1 (enExample)
DK (1) DK2958903T3 (enExample)
DO (1) DOP2015000187A (enExample)
EA (1) EA027756B1 (enExample)
ES (1) ES2625380T3 (enExample)
GE (1) GEP201706749B (enExample)
HR (1) HRP20170607T1 (enExample)
IL (1) IL240501B (enExample)
LT (1) LT2958903T (enExample)
MA (1) MA38338B1 (enExample)
ME (1) ME02671B (enExample)
MX (1) MX362355B (enExample)
MY (1) MY172337A (enExample)
PE (1) PE20151589A1 (enExample)
PH (1) PH12015501807B1 (enExample)
PL (1) PL2958903T3 (enExample)
PT (1) PT2958903T (enExample)
RS (1) RS55932B1 (enExample)
RU (1) RU2652265C2 (enExample)
SG (1) SG11201506651SA (enExample)
SI (1) SI2958903T1 (enExample)
SM (1) SMT201700238T1 (enExample)
TN (1) TN2015000335A1 (enExample)
UA (1) UA116236C2 (enExample)
WO (1) WO2014128207A1 (enExample)
ZA (1) ZA201506050B (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SMT201800065T1 (it) 2010-08-18 2018-03-08 Samumed Llc Dichetoni e idrossichetoni come attivatori della via di segnalazione della catechina
EP2968249B1 (en) 2013-02-22 2018-11-14 Samumed, LLC Gamma-diketones as wnt/beta -catenin signaling pathway activators
ES2762559T3 (es) 2014-08-20 2020-05-25 Samumed Llc Gamma-dicetonas para tratamiento y prevención de envejecimiento de la piel y arrugas
WO2016125191A2 (en) 2015-02-04 2016-08-11 Mylan Laboratories Limited Processes for the preparation of vortioxetine hydrobromide
US20180072690A1 (en) 2015-03-26 2018-03-15 Cipla Limited Methods for Making Serotonin Reuptake Inhibitors
CN106279065A (zh) * 2015-05-12 2017-01-04 北京深蓝海生物医药科技有限公司 一种氢溴酸沃替西汀的精制转晶方法
JO3456B1 (ar) 2015-05-13 2020-07-05 H Lundbeck As فيروتيوكسيتين بيروجلوتامات
EP3414216B1 (en) * 2016-02-08 2020-10-21 AAA Chemistry ApS Arylation of aliphatic amines
TW201806599A (zh) 2016-07-01 2018-03-01 H 朗德貝克公司 用於快速開始抗抑鬱作用之給藥方案
US10519121B2 (en) 2016-12-30 2019-12-31 Apicore Us Llc Process and novel polymorphic form of vortioxetine and its pharmaceutically acceptable salts
US20210393621A1 (en) 2018-10-26 2021-12-23 The Research Foundation For The State University Of New York Combination serotonin specific reuptake inhibitor and serotonin 1a receptor partial agonist for reducing l-dopa-induced dyskinesia
CN109912538B (zh) * 2019-01-22 2021-03-12 安徽赛乐普制药有限公司 一种抗抑郁药沃替西汀的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA81749C2 (uk) * 2001-10-04 2008-02-11 Х. Луннбек А/С Фенілпіперазинові похідні як інгібітори зворотного захоплення серотоніну
DE60219521T2 (de) * 2001-12-20 2007-08-16 H. Lundbeck A/S Aryloxyphenyl und arylsulfanylphenylderivate
ES2432102T3 (es) * 2006-06-16 2013-11-29 H. Lundbeck A/S Compuestos con actividad combinada en SERT, 5-HT3 y 5-HT1A
TW201033181A (en) * 2009-02-17 2010-09-16 Lundbeck & Co As H Purification of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazine

Also Published As

Publication number Publication date
DOP2015000187A (es) 2015-11-30
SI2958903T1 (sl) 2017-09-29
SG11201506651SA (en) 2015-09-29
GEP201706749B (en) 2017-10-10
RU2652265C2 (ru) 2018-04-27
EA027756B1 (ru) 2017-08-31
DK2958903T3 (en) 2017-05-15
PE20151589A1 (es) 2015-12-03
IL240501A0 (en) 2015-09-24
CN104995181B (zh) 2017-03-08
TN2015000335A1 (en) 2017-01-03
CA2901821A1 (en) 2014-08-28
EA201591349A1 (ru) 2015-12-30
MX362355B (es) 2019-01-14
RS55932B1 (sr) 2017-09-29
AU2014220735B2 (en) 2017-06-22
ES2625380T3 (es) 2017-07-19
MA38338B1 (fr) 2018-10-31
IL240501B (en) 2018-08-30
EP2958903B1 (en) 2017-04-12
MX2015010656A (es) 2015-12-17
CL2015002309A1 (es) 2016-03-04
CN104995181A (zh) 2015-10-21
MY172337A (en) 2019-11-21
BR112015019268B1 (pt) 2023-01-10
AU2014220735A1 (en) 2015-08-20
SMT201700238T1 (it) 2017-07-18
PH12015501807A1 (en) 2015-11-09
BR112015019268A2 (pt) 2020-01-28
JP2016509042A (ja) 2016-03-24
EP2958903A1 (en) 2015-12-30
WO2014128207A1 (en) 2014-08-28
ZA201506050B (en) 2017-08-30
PH12015501807B1 (en) 2019-05-31
RU2015134407A (ru) 2017-03-28
ME02671B (me) 2017-06-20
US9353073B2 (en) 2016-05-31
PL2958903T3 (pl) 2017-08-31
CY1118883T1 (el) 2018-01-10
CR20150423A (es) 2015-10-20
JP6464098B2 (ja) 2019-02-06
AP2015008640A0 (en) 2015-08-31
KR102230628B1 (ko) 2021-03-22
KR20150118146A (ko) 2015-10-21
MA38338A1 (fr) 2016-09-30
HRP20170607T1 (hr) 2017-06-30
UA116236C2 (uk) 2018-02-26
US20160009670A1 (en) 2016-01-14
HK1216098A1 (en) 2016-10-14
PT2958903T (pt) 2017-05-26

Similar Documents

Publication Publication Date Title
GB2520596B (en) Manufacturing method
GB201321440D0 (en) Process
GB201312991D0 (en) Process
ZA201506050B (en) Vortioxetine manufacturing process
GB201307334D0 (en) Process
GB201416005D0 (en) Process
GB201421426D0 (en) Process
GB201421428D0 (en) Process
GB201322454D0 (en) Process
GB201318888D0 (en) Process
GB201401963D0 (en) Process
GB201401922D0 (en) Process
GB201322273D0 (en) Process
GB201320869D0 (en) Process
GB201314334D0 (en) Process
GB201307327D0 (en) Process
GB201302441D0 (en) Process
IL239449A0 (en) process
GB201316253D0 (en) Process
GB201307951D0 (en) Process
GB2520796B (en) Process
GB201323151D0 (en) Process
GB201418099D0 (en) Process
GB201303604D0 (en) Manufacturing process
ZA201408020B (en) Cyanide-leaching process